La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Avanos Medical Salute del bilancio
Salute finanziaria criteri di controllo 6/6
Avanos Medical has a total shareholder equity of $1.2B and total debt of $175.1M, which brings its debt-to-equity ratio to 14.3%. Its total assets and total liabilities are $1.7B and $435.8M respectively. Avanos Medical's EBIT is $73.4M making its interest coverage ratio 8.4. It has cash and short-term investments of $92.2M.
Informazioni chiave
14.3%
Rapporto debito/patrimonio netto
US$175.10m
Debito
| Indice di copertura degli interessi | 8.4x |
| Contanti | US$92.20m |
| Patrimonio netto | US$1.22b |
| Totale passività | US$435.80m |
| Totale attività | US$1.66b |
Aggiornamenti recenti sulla salute finanziaria
Is Avanos Medical (NYSE:AVNS) A Risky Investment?
Jan 05
We Think Avanos Medical (NYSE:AVNS) Can Manage Its Debt With Ease
Jun 05Is Avanos Medical (NYSE:AVNS) Using Too Much Debt?
Mar 02Is Avanos Medical (NYSE:AVNS) Using Too Much Debt?
May 03Avanos Medical (NYSE:AVNS) Takes On Some Risk With Its Use Of Debt
Sep 10We Think Avanos Medical (NYSE:AVNS) Is Taking Some Risk With Its Debt
Jun 09Recent updates
There May Be Some Bright Spots In Avanos Medical's (NYSE:AVNS) Earnings
Aug 07Lacklustre Performance Is Driving Avanos Medical, Inc.'s (NYSE:AVNS) Low P/S
Apr 17Is Avanos Medical (NYSE:AVNS) A Risky Investment?
Jan 05Some Avanos Medical, Inc. (NYSE:AVNS) Analysts Just Made A Major Cut To Next Year's Estimates
Aug 14When Should You Buy Avanos Medical, Inc. (NYSE:AVNS)?
Aug 13Avanos Medical: Leaning Up, Attractive Returns On Incremental Capital, Reiterate Buy
Jul 16We Think Avanos Medical (NYSE:AVNS) Can Manage Its Debt With Ease
Jun 05Avanos Medical, Inc. (NYSE:AVNS) Stocks Pounded By 26% But Not Lagging Market On Growth Or Pricing
May 18Avanos Medical (NYSE:AVNS) Is Looking To Continue Growing Its Returns On Capital
May 07Is Avanos Medical (NYSE:AVNS) Using Too Much Debt?
Mar 02Avanos Medical Q4 2022 Earnings Preview
Feb 20Avanos Medical, Inc. (NYSE:AVNS) Shares Could Be 30% Below Their Intrinsic Value Estimate
Feb 10Why Avanos Medical, Inc. (NYSE:AVNS) Could Be Worth Watching
Jan 13Avanos Medical reports Q3 mixed earnings; reaffirms FY22 guidance
Nov 02Avanos: Recent Entry To Hyaluronic Acid Market Sparks Interesting Debate
Sep 12Avanos Medical Q2 2022 Earnings Preview
Aug 08When Should You Buy Avanos Medical, Inc. (NYSE:AVNS)?
May 28Is Avanos Medical (NYSE:AVNS) Using Too Much Debt?
May 03Is There An Opportunity With Avanos Medical, Inc.'s (NYSE:AVNS) 41% Undervaluation?
Feb 10Should You Think About Buying Avanos Medical, Inc. (NYSE:AVNS) Now?
Dec 21An Intrinsic Calculation For Avanos Medical, Inc. (NYSE:AVNS) Suggests It's 33% Undervalued
Nov 04Avanos Medical (NYSE:AVNS) Takes On Some Risk With Its Use Of Debt
Sep 10The Strong Earnings Posted By Avanos Medical (NYSE:AVNS) Are A Good Indication Of The Strength Of The Business
Aug 10Is There Now An Opportunity In Avanos Medical, Inc. (NYSE:AVNS)?
Jun 30We Think Avanos Medical (NYSE:AVNS) Is Taking Some Risk With Its Debt
Jun 09Analisi della posizione finanziaria
Passività a breve termine: AVNS's short term assets ($474.1M) exceed its short term liabilities ($208.2M).
Passività a lungo termine: AVNS's short term assets ($474.1M) exceed its long term liabilities ($227.6M).
Storia e analisi del rapporto debito/patrimonio netto
Livello di debito: AVNS's net debt to equity ratio (6.8%) is considered satisfactory.
Riduzione del debito: AVNS's debt to equity ratio has reduced from 19.4% to 14.3% over the past 5 years.
Copertura del debito: AVNS's debt is well covered by operating cash flow (35.2%).
Copertura degli interessi: AVNS's interest payments on its debt are well covered by EBIT (8.4x coverage).